Search research articles
Contact Us
Filters
Showing results (1491-1500 of 1,688) with videos related to
Page
of 169
Sort By:
Pain Medicine (Malden, Mass.)
|
March 24, 2019
Who Is Keeping Their Unused Opioids and Why?
Luke A Neill, Howard S Kim, Kenzie A Cameron, et al.
British Journal of Cancer
|
December 1, 1996
High-dose chemotherapy supported by peripheral blood progenitor cells in poor prognosis metastatic breast cancer--phase I/II study. Edinburgh Breast Group
D A Cameron, J Craig, H Gabra, et al.
Neuron
|
November 16, 2001
A visual pigment expressed in both rod and cone photoreceptors
J Ma, S Znoiko, K L Othersen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 15, 2023
EBCC-13 manifesto: Balancing pros and cons for contralateral prophylactic mastectomy
Marjanka K Schmidt, Jennifer E Kelly, Anne Brédart, et al.
ACS Medicinal Chemistry Letters
|
September 17, 2021
Reducing the Toxicity of Designer Aminoglycosides as Nonsense Mutation Readthrough Agents for Therapeutic Targets
Michael Popadynec, Alireza Baradaran-Heravi, Benjamin Alford, et al.
Journal of Molecular and Cellular Cardiology
|
February 1, 2011
Association of genetic variation in the natriuretic peptide system with cardiovascular outcomes
Katrina L Ellis, Christopher Newton-Cheh, Thomas J Wang, et al.
Ebiomedicine
|
July 19, 2022
Circulating cardiac biomarkers improve risk stratification for incident cardiovascular disease in community dwelling populations
Zhenqiang Wu, Anna P Pilbrow, Oi Wah Liew, et al.
Breast Cancer Research and Treatment
|
May 8, 2012
Expression of activated type I receptor tyrosine kinases in early breast cancer
Melanie Spears, Hans Christian Pederson, Nicola Lyttle, et al.
Cardiology
|
August 28, 2025
The Prognostic Value of Cardiac Troponin in a Revascularized Cohort with First-time Myocardial Infarction
Nikki J Earle, Katrina K Poppe, Anna P Pilbrow, et al.
BMJ Oncology
|
June 24, 2025
Reduced duration adjuvant trastuzumab in the treatment of patients with HER2-positive breast cancer: a meta-analysis of randomised controlled non-inferiority trials including IPD data
Helena M Earl, Louise Hiller, Janet A Dunn, et al.
Page
of 169
Search research articles
Search
Showing results (1491-1500 of 1,688) with videos related to
Sort By:
Page
of 169
Pain Medicine (Malden, Mass.)
|
March 24, 2019
Who Is Keeping Their Unused Opioids and Why?
Luke A Neill, Howard S Kim, Kenzie A Cameron, et al.
British Journal of Cancer
|
December 1, 1996
High-dose chemotherapy supported by peripheral blood progenitor cells in poor prognosis metastatic breast cancer--phase I/II study. Edinburgh Breast Group
D A Cameron, J Craig, H Gabra, et al.
Neuron
|
November 16, 2001
A visual pigment expressed in both rod and cone photoreceptors
J Ma, S Znoiko, K L Othersen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 15, 2023
EBCC-13 manifesto: Balancing pros and cons for contralateral prophylactic mastectomy
Marjanka K Schmidt, Jennifer E Kelly, Anne Brédart, et al.
ACS Medicinal Chemistry Letters
|
September 17, 2021
Reducing the Toxicity of Designer Aminoglycosides as Nonsense Mutation Readthrough Agents for Therapeutic Targets
Michael Popadynec, Alireza Baradaran-Heravi, Benjamin Alford, et al.
Journal of Molecular and Cellular Cardiology
|
February 1, 2011
Association of genetic variation in the natriuretic peptide system with cardiovascular outcomes
Katrina L Ellis, Christopher Newton-Cheh, Thomas J Wang, et al.
Ebiomedicine
|
July 19, 2022
Circulating cardiac biomarkers improve risk stratification for incident cardiovascular disease in community dwelling populations
Zhenqiang Wu, Anna P Pilbrow, Oi Wah Liew, et al.
Breast Cancer Research and Treatment
|
May 8, 2012
Expression of activated type I receptor tyrosine kinases in early breast cancer
Melanie Spears, Hans Christian Pederson, Nicola Lyttle, et al.
Cardiology
|
August 28, 2025
The Prognostic Value of Cardiac Troponin in a Revascularized Cohort with First-time Myocardial Infarction
Nikki J Earle, Katrina K Poppe, Anna P Pilbrow, et al.
BMJ Oncology
|
June 24, 2025
Reduced duration adjuvant trastuzumab in the treatment of patients with HER2-positive breast cancer: a meta-analysis of randomised controlled non-inferiority trials including IPD data
Helena M Earl, Louise Hiller, Janet A Dunn, et al.
Page
of 169